Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Haradanahalli S. Ravish"'
Autor:
Haradanahalli S. Ravish, Pradip Patel, Giriyanna Gowda, Shamanna Manjula, Doddabele Hanumanthaiah Ashwath Narayana, Gangaboraiah, S.N. Madhusudana, M.K. Sudarshan, Radhe Madhab Tripathy, Asutosh Padhi, Durga Madhab Satapathy, Ramesh Holla, Gadey Sampath, Belludi Yajman Ashwin
Publikováno v:
Human vaccinesimmunotherapeutics. 10(1)
Zydus Cadila Health care, India developed a new purified chick embryo cell rabies vaccine (PCECV, Vaxirab-N; 1 mL) by adapting Pitman–Moore strain of virus on to the chick embryo fibroblast cell line in 2006. During 2007–10, a series of safety an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a561d48c4a66756ed63fe9589de4eaf6
https://pubmed.ncbi.nlm.nih.gov/24030586
https://pubmed.ncbi.nlm.nih.gov/24030586
Autor:
Doddabele Hanumanthaiah Ashwath Narayana, Ramesh Holla, M.K. Sudarshan, Shampur Narayan Madhusudana, Bilagumba Gangaboraiah, Haradanahalli S. Ravish, Belludi Yajaman Ashwin
The currently recommended intradermal regimen for post-exposure prophylaxis spreads over a month period which many times lead to low compliance from the patients. There is a need to introduce and evaluate short course regimens to overcome this proble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd2faeca672f869f5f2458f0044cd75
https://europepmc.org/articles/PMC3551879/
https://europepmc.org/articles/PMC3551879/
Autor:
Bilagumba Gangaboraiah, Haradanahalli S. Ravish, Doddabele Hanumanthaiah Ashwath Narayana, M.K. Sudarshan
The metadata of 10 published studies and 3 vaccine trial reports comprising of 19 vaccine cohorts from four countries conducted over a period of 23 years (1986–2009) was used for metaanalysis. The vaccines studied were purified chick embryo cell va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::289a743449dbac8f3d8d7ec4462503be
https://europepmc.org/articles/PMC3322518/
https://europepmc.org/articles/PMC3322518/
Autor:
Haradanahalli S Ravish
Publikováno v:
Human Vaccines & Immunotherapeutics. 10:319-320
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f39f83ac157b439e9497e093db9b240
https://doi.org/10.4161/hv.26756
https://doi.org/10.4161/hv.26756